Trastuzumab Pamirtecan (DB-1303/BNT323) in patients with previously treated HER2-expressing advanced/metastatic endometrial cancer: First global clinical Phase 2 data
Efficacy and safety of cadonilimab combined with chemotherapy as the first-line treatment for recurrent/advanced endometrial carcinoma: a multi-center, single-arm phase II clinical trial
The social interventions for support in treatment of endometrial cancer and recurrence (SISTER) study: A national randomized controlled trial of peer support vs. usual care in Black women with high-risk endometrial cancer
Using deep learning models to predict Homologous Recombination Deficiency (HRD) in patients with ovarian cancer based on whole slide images at 5x, 10x, 20x, and 40x magnifications
Location: Ballroom B
Speaker: JI Hyun Lee, MD – Yonsei University College Of Medicine
3:28 PM - 3:34 PM AST
Leveraging Artificial Intelligence to Streamline Documentation and Support Patient-Centered Gynecologic Oncology Outpatient Visits
A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor
Development and Validation of A Clinically Applicable Toolkit for Cervical Gastric-Type Adenocarcinoma (GAS):Diagnostic model, Risk Stratification, and Survival Predictive Nomograms
Location: 209
Speaker: Junjun Qiu, PhD – Obstetrics and Gynecology Hospital of Fudan University
Prevalence of germline pathogenic variants in patients with endometrial cancer diagnosed before and after 65 years old within a laboratory-based research registry
Immunohistochemistry for mismatch repair protein expression in endometrial intraepithelial neoplasia is cost effective to diagnose Lynch Syndrome at low population prevalence
Location: 104
Speaker: Hadley Reid – Brigham and Women's Hospital and Massachusetts General Hospital
3:11 PM - 3:14 PM AST
A randomized feasibility study of group-based education intervention for BRCA1/2 pathogenic variant carriers
Comparing Intrathecal Morphine with Intraoperative Lidocaine Infusion to Epidural Anesthesia with Postoperative PCA for Patients Undergoing Exploratory Laparotomy: A Randomized Controlled Trial
Single vs Coinfection of High-Risk Human Papillomavirus in High-Grade Cervical Intraepithelial Neoplasia and Cervical Cancer
Location: Exhibit Hall B
Poster Presenter: Emma Barr, MD – Adventist Health White Memorial
Poster
4:09 PM - 4:16 PM AST
A Retrospective Cross-Sectional Study of Timely vs Not Timely Cervical Cancer Screening Rates Among Urban Women Living with HIV (WLWH) with Positive HPV Screening: CASCADE Clinical Trials Network
Treatment experience in patients (pts) with advanced ovarian cancer (AOC) who received PARP inhibitor (PARPi) as the first-line (1L) maintenance therapy (MTx) in the real world by homologous recombination deficiency (HRD)/BRCA status
Location: Exhibit Hall B
Poster Presenter: Marina Frimer, MD – Zucker School of Medicine at Hofstra / Northwell
Poster
4:09 PM - 4:16 PM AST
Differences in Age at Onset in Chinese Ovarian Cancer Patients with BRCA Germline Mutations: Implications for Timing of Risk-Reducing Surgery
Location: Exhibit Hall B
Poster Presenter: Cuiyu Huang, MD – peking university third hospital
Poster
4:16 PM - 4:23 PM AST
Metachronous breast cancer among women with ovarian cancer and germline BRCA1/2 pathogenic variants: a population-based analysis
Conceptualizing Impacts of Material and Social Insecurity on Clinical Outcomes in Gynecologic Oncology: Developing an intersectional model of precarity and cancer care
Location: Exhibit Hall B
Poster Presenter: Jenny Mao, DO – University of New Mexico
Poster
4:09 PM - 4:16 PM AST
Equity in ADC Therapy: Real-World Outcomes Across Diverse Underrepresented Gynecologic Cancer Populations
Feasibility, acceptability, and nursing workload impact of a texting platform for remote postoperative monitoring in gynecologic oncology surgical patients
Location: Exhibit Hall B
Poster Presenter: Minyoung Jang, MD – Hospital of the University of Pennsylvania
Poster
4:23 PM - 4:30 PM AST
Efficacy Analysis of the Randomized Pilot Clinical Trial of Neuroplasticity-Based Cognitive Training Exercises for GYNecologic Cancer-Related COGnitive Impairment (GYNCOG)
Location: Exhibit Hall B
Poster Presenter: Connor Wang, MD – Northwestern University Feinberg School of Medicine
Poster
4:10 PM - 4:25 PM AST
Stronger Together: The Physician Role in Bringing APPS Into SGO
Tirzepatide and Intermittent Energy Restriction have anti-obesity and anti-tumorigenic effects in a pre-clinical mouse model of obesity-driven endometrial cancer
Expanded Subtype Testing for Circulating Tumor HPV DNA Reliably Detects the Presence of Advanced-Stage and Recurrent Cervical Cancer
Location: Ballroom B
Speaker: Kersten Rothnie, MD – Northwell Health / Long Island Jewish Medical Center
5:04 PM - 5:10 PM AST
Clinical Performance of Signatera Genome Assay to Predict Treatment Response in Patients with Advanced-Stage Ovarian Cancer Receiving Neoadjuvant Chemotherapy
Combination of exportin-1 (XPO1) with Bcl-2/xL inhibition is synergistic in low-grade serous ovarian cancer
Location: 208
Speaker: Dimitrios Nasioudis, MD – University of Pennsylvania, Division of Gynecologic Oncology
4:38 PM - 4:44 PM AST
Combination ATR and PARP Inhibitor (CAPRI) Trial in recurrent platinum-sensitive high-grade serous ovarian cancer demonstrates activity independent of homologous recombination repair status
Factors Supporting Adjuvant Treatment Escalation in High-Risk Stage I-II Endometrioid Endometrial Carcinoma: A Propensity Score Weighed Investigation
Location: 104
Speaker: Samantha Leite, MD – National Capital Consortium (Walter Reed National Military Medical Center, Inova Fairfax, MedStar)
5:08 PM - 5:11 PM AST
Similar Survival Outcomes Following Adjuvant Chemotherapy Versus Observation in Low-Grade, Stage I Endometrioid Ovarian, Tubal and Peritoneal Carcinoma: A Propensity Score Weighted Analysis
Location: 104
Speaker: Samantha Leite, MD – National Capital Consortium (Walter Reed National Military Medical Center, Inova Fairfax, MedStar)
5:11 PM - 5:14 PM AST
Prediction of Response to Fertility Preserving Progestin Therapy for Endometrial Cancer Based on Molecular Subtype
